Examining the Effect of a Group-Based Stress Management Course on Empowering the Mental Health of Medical Faculty Students and Resident Physicians: A Randomized Controlled Study
EMPOWER-MD
EXAMINING THE EFFECT OF A GROUP-BASED STRESS MANAGEMENT COURSE ON EMPOWERING THE MENTAL HEALTH OF MEDICAL FACULTY STUDENTS AND RESIDENT PHYSICIANS: A RANDOMIZED CONTROLLED STUDY
1 other identifier
interventional
180
1 country
1
Brief Summary
Physicians and medical students have higher rates of depression, anxiety, burnout, and suicide risk than the general population, and this disparity often begins early, even during medical school. Despite substantial distress, help-seeking is frequently limited due to stigma concerns, career fears, and time constraints, which may allow mental health problems to progress unnoticed and become chronic. Preventive interventions during medical education may reduce current distress and help avert more severe disorders later in professional life. Group-based psychoeducation is a cost-effective approach with advantages such as scalability, peer support, and learning benefits without requiring personal disclosure. The WHO Self-Help Plus (SH+) program is an ACT-informed, easily deliverable group stress management course, and randomized controlled trials across settings suggest SH+ can reduce psychological distress and depressive symptoms while improving coping skills and resilience. In Türkiye, evidence on group-based interventions for medical students and resident physicians remains limited and focuses mainly on documenting symptom levels rather than testing interventions; therefore, this study aims to evaluate a group-based stress management course and examine the feasibility and cultural adaptation of SH+-like programs in Turkish medical education.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2026
CompletedFirst Submitted
Initial submission to the registry
June 25, 2026
CompletedFirst Posted
Study publicly available on registry
July 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
July 1, 2026
June 1, 2026
2.1 years
June 25, 2026
June 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Depression Anxiety Stress Scales - Short Form (DASS-21)
The DASS-21 is a self-report instrument developed to assess respondents' levels of depression, anxiety, and stress (Lovibond \& Lovibond, 1995).
1th-30th days
Suicide Probability Scale - SPS
The original form of the scale was developed by Cull and Gill (1982) to measure the likelihood of suicide.
1 th - 30 th days
Secondary Outcomes (1)
The World Health Organization-Five Well-Being Index - WHO-5
1 th - 30 th days
Other Outcomes (2)
Maslach Burnout Inventory (MBI)
1th - 30 th days
The Multidimensional Scale of Perceived Social Support - MSPSS
1 th - 30 th days
Study Arms (2)
intervention group
EXPERIMENTALThe group will receive 5 sessions of group based stress management program developed by WHO.
Waiting list
NO INTERVENTIONWaiting list
Interventions
The course is designed to help individuals cope with challenging life events and manage stress. The core components of the SH+ course include focusing attention (grounding), stepping back from distressing thoughts and emotions, acting in line with one's values, practicing kindness (self-compassion), and making space for difficult emotions.
Eligibility Criteria
You may qualify if:
- Being a medical student or a resident physician at Eskişehir Osmangazi University Faculty of Medicine
- Being 18 years of age or older
You may not qualify if:
- Individuals with active suicidal ideation
- Individuals with severe mental disorders such as psychotic disorders or bipolar disorder
- Individuals with alcohol or substance dependence
- Students under 18 years of age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Eskişehir Osmangazi University
Eskişehir, 26040, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor doctor
Study Record Dates
First Submitted
June 25, 2026
First Posted
July 1, 2026
Study Start
January 1, 2026
Primary Completion (Estimated)
February 1, 2028
Study Completion (Estimated)
December 31, 2028
Last Updated
July 1, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share
Since our participants will be medical students and residents from the same medical faculty, we anticipate that publicly sharing data may compromise anonymity.